Medical Research Trends

This week's highest-impact publications across 29 specialties, curated by AI

Last updated: Jul 28, 2026

Oncology5 articles

Impact 1

Clinical features of systemic amyloidosis: a scoping review.

Published: 2026-07-28

Blood advances

Medical Digest Indexed: 2026-07-29

(Summary generation failed. Please refer to the original article.)

Read on PubMed
Impact 1

Nitroalkenes exploit dependence on autophagy-lysosome pathway in PARPi-Resistant triple negative breast cancer.

Published: 2026-07-28

Cancer letters

Medical Digest Indexed: 2026-07-29

(Summary generation failed. Please refer to the original article.)

Read on PubMed
Impact 3

GBP6 maintains mitochondrial bioenergetics to promote immune evasion from NK cells in cervical cancer.

Published: 2026-07-27

Cell reports

Medical Digest Indexed: 2026-07-29

This study identifies GBP6 as a mitochondrial factor associated with aggressive cervical cancer, enriched in high-risk tumors and correlating with poor clinical outcomes. GBP6 knockdown suppresses tumor cell proliferation and promotes cell death by disrupting mitochondrial bioenergetics and induc...

Read on PubMed
Impact 3

Spatiotemporally Ultrasound-Controlled Nanoparticles Reprogramming Immunostimulatory Antigen-Presenting Cancer-Associated Fibroblasts to Enhance Cancer Immunotherapy.

Published: 2026-07-27

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Medical Digest Indexed: 2026-07-29

This study focuses on reprogramming myofibroblastic cancer-associated fibroblasts (CAFs) into immune activated antigen presenting CAFs (apCAFs) as a treatment for fibrotic breast cancer. Using a spatiotemporally ultrasound-controlled nanoparticle, the researchers successfully reprogrammed myCAFs ...

Read on PubMed
Impact 3

Targeting TOMM40 unleashes immunogenic mitophagy to facilitate antigen presentation and immunotherapy sensitization.

Published: 2026-07-27

Journal for immunotherapy of cancer

Medical Digest Indexed: 2026-07-29

This study explores the role of mitophagy in cancer immunogenicity, identifying TOMM40 as a gatekeeper of mitochondrial import that restrains mitophagy. Loss of TOMM40 induces mitochondrial dysfunction and hyperactivated mitophagy, converting immune-cold tumors into immune-inflamed states with in...

Read on PubMed

Get Personalized Daily Summaries

Join physicians worldwide who start their morning with AI-curated literature reviews, delivered to your inbox at 7 AM.

Start 14-Day Free Trial